Jennings H. Keith
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Susquehanna Keeps Neutral Rating on Noble Corp, Raises Target to $44. Susquehanna Research maintained a neutral stance on Noble Corporation and increased its price target to $44 per share. The new target sits below the consensus analyst median of $48.55 and is close to the recent $45.48 support level observed on the chart. The adjustment reflects the firm's view of the company's current valuation amid a trailing P/E of 44.2 and a dividend yield of 4.43%.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
FEAM Featured in Analyst Reports and CEO Discusses Acquisition. A Benzinga article listed FEAM among three materials stocks that could experience a sharp decline this quarter. At a Water Tower Research conference, CEO Paul Weibel outlined the Searles Valley acquisition agreement and described how the deal is expected to generate revenue. FEAM also appeared in a Seeking Alpha roundup of lithium junior miners for September 2026.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
WFRD analyst price target cuts. Barclays kept an overweight rating on Weatherford International but reduced its price target to $148. Goldman Sachs also maintained a neutral stance while lowering its target to $94. A recent Yahoo piece noted expectations for earnings growth at the company. These analyst adjustments reflect mixed views on the stock’s near‑term outlook.
Transaction History
| ARRY | ▲ Buy | Option Exercise | 40,782 | — | 3/18/2026 | View on chart |
| ARRY | ▼ Sell | Tax Withholding | 11,614 | $80K | 3/18/2026 | View on chart |
| NE | ▲ Buy | Option Exercise | 3,673 | $0 | 2/3/2026 | View on chart |
| NE | ▲ Buy | Option Exercise | 2,716 | $0 | 1/26/2025 | View on chart |
| NE | ▲ Buy | Option Exercise | 515 | $0 | 11/22/2024 | View on chart |
| FEAM | ▲ Buy | Option Exercise | 7,947 | — | 7/1/2024 | View on chart |
| FEAM | ▼ Sell | Tax Withholding | 2,941 | $4K | 7/1/2024 | View on chart |
| FEAM | ▲ Buy | Option Exercise | 11,099 | — | 7/1/2024 | View on chart |
| FEAM | ▼ Sell | Tax Withholding | 4,107 | $5K | 7/1/2024 | View on chart |
| FEAM | ▲ Buy | Option Exercise | 17,232 | — | 7/1/2024 | View on chart |
| FEAM | ▼ Sell | Tax Withholding | 6,376 | $8K | 7/1/2024 | View on chart |
| FEAM | ▲ Buy | Option Exercise | 17,233 | — | 7/1/2024 | View on chart |
| FEAM | ▼ Sell | Tax Withholding | 6,377 | $8K | 7/1/2024 | View on chart |
| FEAM | ▲ Buy | Option Exercise | 2,983 | — | 7/3/2023 | View on chart |
| FEAM | ▼ Sell | Tax Withholding | 1,104 | $4K | 7/3/2023 | View on chart |
| FEAM | ▲ Buy | Option Exercise | 1,213 | — | 7/3/2023 | View on chart |
| FEAM | ▼ Sell | Tax Withholding | 449 | $1K | 7/3/2023 | View on chart |
| FEAM | ▲ Buy | Option Exercise | 5,693 | — | 7/3/2023 | View on chart |
| FEAM | ▼ Sell | Tax Withholding | 2,107 | $7K | 7/3/2023 | View on chart |
| WFRD | ▲ Buy | Option Exercise | 57,898 | $0 | 1/4/2022 | View on chart |
| WFRD | ▲ Buy | Option Exercise | 23,485 | $0 | 1/4/2022 | View on chart |
| WFRD | ▼ Sell | Other | 23,485 | $650K | 1/4/2022 | View on chart |
| WFRD | ▼ Sell | Tax Withholding | 17,669 | $493K | 1/4/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
UBS Downgrades Array Technologies to Neutral, Cuts Target to $5
UBS downgraded Array Technologies to Neutral and lowered its price target to $5, citing concerns about the company's outlook. This move contributed to a broader wave of analyst downgrades, with the average target price across 22 analysts falling to $8.60. The stock recently dropped 2.70% and is currently trading near its 52-week low, reflecting heightened market skepticism.
UBS Downgrades Array Technologies to Neutral, Cuts Target to $5. UBS downgraded Array Technologies to Neutral and lowered its price target to $5, citing concerns about the company's outlook. This move contributed to a broader wave of analyst downgrades, with the average target price across 22 analysts falling to $8.60. The stock recently dropped 2.70% and is currently trading near its 52-week low, reflecting heightened market skepticism.